Abivax (ABVX) EBT (2024 - 2026)

Abivax's EBT history runs 3 years deep, the most recent figure standing at -$56.5 million for Q1 2026.

• In Q1 2026, EBT fell 2.52% year-over-year to -$56.5 million; the TTM figure through Mar 2026 stood at -$379.2 million (down 90.06% YoY), while the FY2025 annual figure was -$384.5 million, down 104.2% from the prior year.
• EBT was -$56.5 million for Q1 2026 at Abivax, up from -$88.7 million in the prior quarter.
• In the past five years, EBT ranged from a high of -$41.8 million in Q2 2024 to a low of -$179.3 million in Q3 2025.
• Historically, EBT has averaged -$69.5 million across 3 years, with a median of -$55.1 million in 2025.
• The sharpest annual moves came in 2025 and 2026: EBT slumped 195.6% in 2025, then retreated 2.52% in 2026.
• A 3-year view of EBT shows it stood at -$42.0 million in 2024, then slumped by 110.9% to -$88.7 million in 2025, then soared by 36.29% to -$56.5 million in 2026.
• The last three EBT figures came in at -$56.5 million (Q1 2026), -$88.7 million (Q4 2025), and -$179.3 million (Q3 2025), per Business Quant data.